Transcriptomic heterogeneity of cultured ADSCs corresponds to embolic risk in the host

Stem cell therapy emerges as an effective approach for treating various currently untreatable diseases. However, fatal and unknown risks caused by their systemic use remain to be a major obstacle to clinical application. We developed a functional single-cell RNA sequencing (scRNA-seq) procedure and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Kaijing, Zhang, Jinlai, Yin, Wen, Harding, Jeffrey N., Ma, Fei, Wu, Di, Deng, Haibo, Han, Pengfei, Li, Rui, Peng, Hongxu, Song, Xin, Kang, Y. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389247/
https://www.ncbi.nlm.nih.gov/pubmed/35992088
http://dx.doi.org/10.1016/j.isci.2022.104822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389247/
https://www.ncbi.nlm.nih.gov/pubmed/35992088
http://dx.doi.org/10.1016/j.isci.2022.104822

Ejemplares similares